View the Webinar (2:34:41)
The NIDA HIV Research Program hosted a symposium in September 2022 with awardees of the Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS, supporting early-stage investigators at the forefront of HIV research among people who use drugs, featuring:
- Jacqueline Linnes, Ph.D., Purdue University
Towards Acute HIV Infection Detection at the Point-of-Use
- Brandon Marshall, Ph.D., Brown University
Agent-based modeling to estimate the impact of syringe service programs on HIV transmission among people who inject drugs
- Gregg Gonsalves, Ph.D.. Yale University
An Adaptive Approach to Active Surveillance for HIV (and SARSCoV2)
- Annick Bórquez, Ph.D., University of California, San Diego
Predicting drug-related epidemics in the United States
- Ian Holloway, Ph.D., University of California, Los Angeles
uTECH: Machine Learning for HIV Prevention Among Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
You can also review the 2021 Avenir Symposium, providing an insightful look at other groundbreaking early-stage investigators at the intersection of the prevention, treatment, and eradication of HIV and substance use.
HRP also funds the complementary Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research to support potentially transformative studies by investigators at all career levels, and hosted the Avant-Garde Award Symposium in May 2022 to highlight recent award recipients and their research.
Contact HIVNews@nida.nih.gov for more information and updates on the HIV Avenir and Avant-Garde Awards.